http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2171811-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C277-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate | 1990-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2171811-C2 |
| titleOfInvention | CRYSTALLINE DEOXYSPERGUALINE TRIHYDROCHLORIDE IN β-FORM ELICITING ANTITUMOR ACTIVITY AND METHOD OF ITS PREPARING |
| abstract | FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to crystalline deoxyspergualine trihydrochloride in β-form of the formula: β- exhibiting the following parameters of roentgen-ray diffraction in powder-like state: : 15.77; 10.91; 4.88; 4.67 : 0.32; 0.42; 0.39; 0.53 I/I I : 4.14; 3.66; 3.31; 3.21 : 0.70; 1.00; 0.52; 0.52 that shows antitumor activity and to method of its preparing. Method of preparing involves crystallization of powder or syrup-like aqueous suspension of deoxyspergualine trihydro-chloride from an aqueous ethanol at the concentration of water 15 vol. %, not above. EFFECT: improved method of preparing, valuable antitumor properties. 2 cl, 5 tbl, 2 dwg |
| priorityDate | 1989-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.